Category:LBS: Difference between revisions

Revision as of 02:02, 28 January 2023

Sphingolipid

Upper classes: LB

Class Overview

Three Sphingolipid categories (LBS) exist in this database.

このデータベースではスフィンゴ脂質を以下に分けています。

		\|	OH
(C₁₄-chain)	＝	／	＼	／	ー	OH
(fatty acid) ー			\|	NH

セラミド

Glycosphingolipid

		\|	OH
(C₁₄-chain)	＝	／	＼	／	ー	O-(sugar)
(fatty acid) ー			\|	NH

スフィンゴ糖脂質

Phosphosphingolipid

		\|	OH
(C₁₄-chain)	＝	／	＼	／	ー	O-(phosphate)
(fatty acid) ー			\|	NH

スフィンゴリン脂質

Long-chain base and ceramide

Sphingomyelin, CPE, CAEP and GIPC

Go to Sphingolipid search.

History of Sphingolipids

Sphingolipids were first isolated from brain by J.L.W. Thudichum (1829-1901) as lipids of unknown function and structure.^[1] The basic structure is a long-chain base (long-chain amino-alcohol) whose amino-group is acylated with a long-chain fatty acid. This hydrophobic structure is called ceramides. Sphingolipid consists of phospho-sphingolipid and glyco-sphingolipid, whose ceramide structure is bonded with phosphate and (oligo)saccharides, respectively. Phosphosphingolipid includes sphingomyelin, and glycosphingolipid, cerebrosides and gangliosides. Both are abundant in neural tissues.^[2]

スフィンゴ脂質は J.L.W. Thudichum (1829-1901) により機能や構造未知の脂質として脳から見いだされました。基本骨格は長鎖塩基 (長鎖アミノアルコール) のアミノ基が長鎖脂肪酸とアミド結合したもので、セラミドと呼ばれます。スフィンゴ脂質はセラミドにリン酸が結合したスフィンゴリン脂質と糖が結合したスフィンゴ糖脂質に分けられます。スフィンゴリン脂質にはスフィンゴミエリンが、スフィンゴ糖脂質にはセレブロシドやガングリオシドなどが含まれ、いずれも神経系に多く存在します。

↑ Thudichum J.L.W.?"A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London,?1884
↑ Gault CR,?Obeid LM,?Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol.?2010;688:1-23. PMID 20919643

Sphingolipid

Notation

Symbol Abbreviations (e.g. Glc = glucose)
Backbones
Cer	ceramide	セラミド
Sph	sphingosine	スフィンゴシン
Sugars
Glc	glucose	グルコース
Gal	galactose	ガラクトース
GlcNAc	N-acetyl-glucosamine	N-アセチルグルコサミン
GalNAc	N-acetyl-galactosamine	N-アセチルガラクトサミン
GlcN	glucosamine	グルコサミン
GalN	galactosamine	ガラクトサミン
GlcA	glucuronic acid	グルクロン酸
GalA	galacturonic acid	ガラクツロン酸
Man	mannose	マンノース
Rha	rhamnose (= 6-deoxy-mannose)	ラムノース (6-デオキシマンノース)
Ins	inositol	イノシトール
Fuc	fucose (= 6-deoxy-galactose)	フコース (6-デオキシガラクトース)
Ara	arabinose	アラビノース
Xyl	xylose	キシロース
NeuNH	(deacetyl) neuraminic acid (pyruvate + mannosamine)	ノイラミン酸 (ピルビン酸＋マンノサミン)
NeuAc	N-acetyl-neuraminic acid	N-アセチルノイラミン酸
NeuGc	N-glycolyl-neuraminic acid	N-グリコリルノイラミン酸
Kdn	2-keto-3-deoxy-D-glycero- D-galacto-nononic acid	デアミノノイラミン酸
Modifiers
AEPn	aminoethylphosphonic acid, or (2-aminoethyl)hydroxyphosphoryl-	アミノエチルホスホン酸（C-P結合）
MAEPn	N-methyl aminoethylphosphonic acid, or (N-methyl-2-aminoethyl) hydroxyphosphoryl-	AEPnのN-メチル体（C-P結合）
EtnP	phosphoethanolamine (PEA), or 2-aminoethanolphospho-	ホスホエタノールアミン
PC	Phosphocholine	ホスホコリン
Butenyl	Butenyl	ブテニル基
Me	Methyl	メチル基
Et	Ethyl	エチル基

Page/ID-Code Design

Major series of phosphosphingolipids are determined by molecules bound to their phosphates, and the series of glycosphingolipids are determined by oligosaccharides bound to their ceramides. The IUPAC series of glycosphingolipids (1977) were based on the order and bonding patterns of four sugars rooting at the long-chain base. Our series, however, are based on three sugars. Two original series, Echino and Schisto, are also added.

スフィンゴリン脂質はリン酸に結合する分子や糖の種類、スフィンゴ糖脂質はセラミドに結合する糖鎖により系列を作成しています。1977年にIUPACが提唱したスフィンゴ糖脂質の系列は、長鎖塩基に結合する四糖の並びと結合を基準にしています。ここではより広い糖鎖の系列を検索できるよう、三糖を基準に分類しています。また新たにEchinoとSchistoの系列を加えています。

L

B

S

G/P

s1

s2

n1

n2

y

c1

c2

G/P	G (glyco)	P (phospho)
s1, s2	structure code as explained below
n1, n2	number of sugars (2 digits)
y	number of sialic acids (1 digit)
c1, c2	serial numbers

First (s1) Digit for Glycosphingolipid

First sugar

Code

Root sequence

Major Series

Cerebroside

For GalCer and GlcCer, visit this page.

starting with
Galactose

LBSG1|G1
(LBSG1.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|79 items)

Gal-Cer

Mainchain.*Gala1-4?6?Galb1-Cer\|Gala / Neogala	Gal_α1-4/6Gal_β1-Cer
Mainchain.*Galb1-4Glcb1-3Galb1-Cer\|Spirometo	Gal_β1-4Glc_β1-3Gal_β1-Cer

starting with
Glucose

LBSG2|G2
(LBSG2.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|88 items)

GalNAc_β-Gal_β-Glc_β-Cer

Mainchain.*GalNAcb1-4Galb1-4Glcb1-Cer\|Ganglio	GalNAc_β1-4Gal_β1-4Glc_β1-Cer
Mainchain.*GalNAcb1-3Galb1-4Glcb1-Cer\|Isoganglio^[1]	GalNAc_β1-3Gal_β1-4Glc_β1-Cer
Structure.GlcNAcb1-3\(.GalNAcb1-4\)Galb1-4Glcb1-Cer\|Lactoganglio	GlcNAc_β1-3(GalNAc_β1-4)Gal_β1-4Glc_β1-Cer
Structure.*\(?NeuAca2-3\)?Galb1-4Glcb1-Cer\|a-series	GalNAc_β1-4(NeuAc_α2-3)Gal_β1-4Glc_β1-Cer
Structure.*\(?NeuAca2-8NeuAca2-3\)?Galb1-4Glcb1-Cer\|b-series	GalNAc_β1-4(NeuAc_α2-8NeuAc_α2-3)Gal_β1-4Glc_β1-Cer
Structure.*\(?NeuAca2-8NeuAca2-8NeuAca2-3\)?Galb1-4Glcb1-Cer\|c-series	GalNAc_β1-4(NeuAc_α2-8NeuAc_α2-8NeuAc_α2-3)Gal_β1-4Glc_β1-Cer
Structure.*\(?NeuAca2-6\)?GalNAcb1-4Galb1-4Glcb1-Cer\|α-series	...(NeuAc_α2-6)GalNAc_β1-4Gal_β1-4Glc_β1-Cer
Structure.*\(?NeuAca2-8NeuAca2-6\)?GalNAcb1-4Galb1-4Glcb1-Cer\|β-series	...(NeuAc_α2-8NeuAc_α2-6)GalNAc_β1-4Gal_β1-4Glc_β1-Cer

LBSG3|G3
(LBSG3.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|173 items)

GlcNAc_β-Gal_β-Glc_β-Cer

Mainchain.*Galb1-3GlcNAcb1-3Galb1-4Glcb1-Cer\|Lacto	Gal_β1-3GlcNAc_β1-3Gal_β1-4Glc_β1-Cer
Mainchain.*Gal.1-4GlcNAcb1-3Galb1-4Glcb1-Cer\|Neolacto^[2]	Gal_β1-4GlcNAc_β1-3Gal_β1-4Glc_β1-Cer

LBSG4|G4
(LBSG4.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|55 items)

Gal_α-Gal_β-Glc_β-Cer

Mainchain.*Gala1-4Galb1-4Glcb1-Cer\|Globo	Gal_α1-4Gal_β1-4Glc_β1-Cer
Mainchain.*Gala1-3Galb1-4Glcb1-Cer\|Isoglobo^[1]	Gal_α1-3Gal_β1-4Glc_β1-Cer

LBSG5|G5
(LBSG5.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|113 items)

Gal-Glc-Cer
(Other than G2∼G4)

Mainchain.*Galb1-4Galb1-4Glcb1-Cer|Muco

Gal_β1-4Gal_β1-4Glc_β1-Cer

LBSG6|G6
(LBSG6.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|68 items)

Man-Glc_β-Cer

Mainchain.*GlcNAcb1-3Manb1-4Glcb1-Cer\|Arthro	GlcNAc_β1-3Man_β1-4Glc_β1-Cer
Mainchain.*Mana1-3Manb1-4Glcb1-Cer\|Mollu	Man_α1-3Man_β1-4Glc_β1-Cer

LBSG7|G7
(LBSG7.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|21 items)

NeuAc/NeuGc-Glc_β-Cer

Mainchain.*Neu(A~G)c.2-6Glcb1-Cer|Echino

NeuGc or NeuAc_α2-6Glc_β1-Cer

LBSG8|G8
(LBSG8.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids|12 items)

GalNAc-Glc-Cer

Mainchain.*GalNAc.1-4Glc.1-Cer|Schisto^[3]

GalNAc_β1-4Glc_β1-Cer

starting with
Other Sugars

LBSG(A~B~C~D~E~F~G~H~J~K~M~N~O~P~Q~R)|G(A∼R)

Symbols follow the Sugar-digit table.

↑ ^1.0 ^1.1 In IUPAC, "iso" refers to a change from position 4 to position 3.
↑ In IUPAC, "neo" refers to a change from position 3 to position 4.
↑ Makaaru CK, Damian RT, Smith DF, Cummings RD. "The human blood fluke Schistosoma mansoni synthesizes a novel type of glycosphingolipid" J Biol Chem 1992 267:2251-2257 PMID 1733932

First (s1) Digit for Phosphosphingolipid

First sugar

Code

Root sequence

Major Series

No Sugar Attached

P1 (LBSP)

R-P-Cer

Sphingomyelin and Ceramide phosphoetanolamine
(Visit this page.)

starting with
Inositol

LBSP2|P2
(29 items)

GlcN_α/β1−2/6Ins₁-P-Cer

Mainchain.*GlcN.1-.Ins-P-Cer|Protozoa & Fungi-specific

GlcN_α/β1-2/6Ins1-P-Cer

LBSP3|P3
(10 items)

GlcA_α/β1−2/6Ins₁-P-Cer

Mainchain.*GlcA.1-.Ins-P-Cer|Plant-specific

GlcA_α/β1-2/6Ins1-P-Cer

LBSP4|P4
(52 items)

Man_α/β1−2/6Ins₁-P-Cer

Mainchain.*Man.1-.Ins-P-Cer|Fungi-specific

Man_α/β1-2/6Ins1-P-Cer

LBSP5|P5
(21 items)

Others

Ins1-P-Cer

Second (s2) Digit

Click to see the full list. For abbreviations, see #Notation.

Code	Structure
A	Glc
B	Gal
C	GlcNAc
D	GalNAc
E	GlcN
F	GalN
G	GlcA
H	GalA
I	not used

Code	Structure
J	Structure.*Man\|Mannose
K	Structure.*Rha\|Rhamnose
L	%53%74%72%75%63%74%75%72%65%2e%2A%49%6e%73%28%4d%65%29%3F%2d%50%2d%5B%5E%43%65%72%5D\|Inositol
M	Fucose (%53%74%72%75%63%74%75%72%65%5B%5E%46%5D%2B%46%75%63%5B%5E%46%5D%2B%24\| 1, %53%74%72%75%63%74%75%72%65%28%5B%5E%46%5D%2B%46%75%63%29%7B%32%7D%5B%5E%46%5D%2B%24\|2, %53%74%72%75%63%74%75%72%65%28%5B%5E%46%5D%2B%46%75%63%29%7B%33}\|>3)
N	Structure.*Ara\|Arabinose
O	Structure.*Xyl\|Xylose
P	Structure.*(NeuAc~NeuNH)\|NeuAc / NeuNH
Q	Structure.*(NeuGc)\|NeuGc
R	Structure.*(KDN)\|Kdn

Code	Structure
S	Structure.*(Phospho)\|Phosphate (except GIPC)
T	Structure.(AEPn)\|(M)AEPn, Structure.(EtnP)\|EtnP, Structure.*(PC)\|PC
U	Structure.*Sulfo\|Sulfate
V	acyl/alkyl/alkenyl chain

Biosynthesis

Sphingosine is synthesized from decarboxylating condensation of palmitoyl CoA with serine on the ER membrane. It is a 18-carbon amino alcohol (16 carbons from palmitic acid and 2 from serine) with one unsaturated bond (trans-form) at the C-4 position (2-amino-4-octadecene-1,3-diol). (more details)

スフィンゴシンはパルミトイルCoAがアミノ酸セリンと脱炭酸縮合して生成します。炭素を18個含むアミノアルコール(16個がパルミチン酸、2個がセリン由来)でトランス型の不飽和結合をC-4に1つ含みます。（詳細はこちら）

Subcategories

This category has the following 4 subcategories, out of 4 total.

L

[1] Thudichum J.L.W.?"A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London,?1884

[2] Gault CR,?Obeid LM,?Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol.?2010;688:1-23. PMID 20919643

[iso-3] 1.0 ^1.1 In IUPAC, "iso" refers to a change from position 4 to position 3.

[neo-4] In IUPAC, "neo" refers to a change from position 3 to position 4.

[5] Makaaru CK, Damian RT, Smith DF, Cummings RD. "The human blood fluke Schistosoma mansoni synthesizes a novel type of glycosphingolipid" J Biol Chem 1992 267:2251-2257 PMID 1733932

[1]

[2]

[1]

[2]

[3]

@@ Line 42: / Line 42: @@
 ==={{Bilingual|スフィンゴ脂質の歴史|History of Sphingolipids}}===
 {{Twocolumn|
-Sphingolipids were first isolated from brain by J.L.W. Thudichum (1829-1901) as lipids of unknown function and structure.<ref>Thudichum J.L.W. "A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London, 1884</ref> The basic structure is a long-chain base (long-chain amino-alcohol) whose amino-group is acylated with a long-chain fatty acid. This hydrophobic structure is called ceramides.
+Sphingolipids were first isolated from brain by J.L.W. Thudichum (1829-1901) as lipids of unknown function and structure.<ref>Thudichum J.L.W.?"A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London,?1884</ref> The basic structure is a long-chain base (long-chain amino-alcohol) whose amino-group is acylated with a long-chain fatty acid. This hydrophobic structure is called ceramides.
-Sphingolipid consists of phospho-sphingolipid and glyco-sphingolipid, whose ceramide structure is bonded with phosphate and (oligo)saccharides, respectively. Phosphosphingolipid includes sphingomyelin, and glycosphingolipid, cerebrosides and gangliosides. Both are abundant in neural tissues.<ref>Gault CR, Obeid LM, Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol. 2010;688:1-23. PMID 20919643</ref>
+Sphingolipid consists of phospho-sphingolipid and glyco-sphingolipid, whose ceramide structure is bonded with phosphate and (oligo)saccharides, respectively. Phosphosphingolipid includes sphingomyelin, and glycosphingolipid, cerebrosides and gangliosides. Both are abundant in neural tissues.<ref>Gault CR,?Obeid LM,?Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol.?2010;688:1-23. PMID 20919643</ref>
 |
 スフィンゴ脂質は J.L.W. Thudichum (1829-1901) により機能や構造未知の脂質として脳から見いだされました。基本骨格は長鎖塩基 (長鎖アミノアルコール) のアミノ基が長鎖脂肪酸とアミド結合したもので、セラミドと呼ばれます。
@@ Line 154: / Line 154: @@
 {| style="width:100%;"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Gala1-4?6?Galb1-Cer|Gala / Neogala]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Gala1-4/6Galb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Gala1-4/6Galb1-Cer}}
 |-
 |style="border:0;text-align:left"|[[Volatile:ListMol/LBS|Mainchain.*Galb1-4Glcb1-3Galb1-Cer|Spirometo]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Galb1-4Glcb1-3Galb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-4Glcb1-3Galb1-Cer}}
 |}
 |-
@@ Line 168: / Line 168: @@
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*GalNAcb1-4Galb1-4Glcb1-Cer|Ganglio]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GalNAcb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*GalNAcb1-3Galb1-4Glcb1-Cer|Isoganglio]]<ref name="iso">In IUPAC, "iso" refers to a change from position 4 to position 3.</ref>
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GalNAcb1-3Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-3Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Structure.*GlcNAcb1-3\(.*GalNAcb1-4\)Galb1-4Glcb1-Cer|Lactoganglio]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GlcNAcb1-3(GalNAcb1-4)Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcNAcb1-3(GalNAcb1-4)Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Structure.*\(?NeuAca2-3\)?Galb1-4Glcb1-Cer|a-series]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Structure.*\(?NeuAca2-8NeuAca2-3\)?Galb1-4Glcb1-Cer|b-series]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Structure.*\(?NeuAca2-8NeuAca2-8NeuAca2-3\)?Galb1-4Glcb1-Cer|c-series]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Structure.*\(?NeuAca2-6\)?GalNAcb1-4Galb1-4Glcb1-Cer|&alpha;-series]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|...(NeuAca2-6)GalNAcb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|...(NeuAca2-6)GalNAcb1-4Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Structure.*\(?NeuAca2-8NeuAca2-6\)?GalNAcb1-4Galb1-4Glcb1-Cer|&beta;-series]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|...(NeuAca2-8NeuAca2-6)GalNAcb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|...(NeuAca2-8NeuAca2-6)GalNAcb1-4Galb1-4Glcb1-Cer}}
 |}
 |-
@@ Line 198: / Line 198: @@
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Galb1-3GlcNAcb1-3Galb1-4Glcb1-Cer|Lacto]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Galb1-3GlcNAcb1-3Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-3GlcNAcb1-3Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Gal.1-4GlcNAcb1-3Galb1-4Glcb1-Cer|Neolacto]]<ref name="neo">In IUPAC, "neo" refers to a change from position 3 to position 4.</ref>
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Galb1-4GlcNAcb1-3Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-4GlcNAcb1-3Galb1-4Glcb1-Cer}}
 |}
 |-
@@ Line 210: / Line 210: @@
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Gala1-4Galb1-4Glcb1-Cer|Globo]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Gala1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Gala1-4Galb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Gala1-3Galb1-4Glcb1-Cer|Isoglobo]]<ref name="iso"/>
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Gala1-3Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Gala1-3Galb1-4Glcb1-Cer}}
 |}
 |-
@@ Line 221: / Line 221: @@
 {| style="width:100%"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Galb1-4Galb1-4Glcb1-Cer|Muco]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Galb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-4Galb1-4Glcb1-Cer}}
 |}
 |-
@@ Line 229: / Line 229: @@
 {| style="width:100%"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*GlcNAcb1-3Manb1-4Glcb1-Cer|Arthro]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GlcNAcb1-3Manb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcNAcb1-3Manb1-4Glcb1-Cer}}
 |-
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Mana1-3Manb1-4Glcb1-Cer|Mollu]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|Mana1-3Manb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Mana1-3Manb1-4Glcb1-Cer}}
 |}
 |-
@@ Line 240: / Line 240: @@
 {| style="width:100%"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Neu(A~G)c.2-6Glcb1-Cer|Echino]]
-|style="border:0;text-align:right"| <font color=purple>'''NeuGc'''</font> or {{LBS/FormatSugar|NeuAca2-6Glcb1-Cer}}
+|style="border:0;text-align:right"| <font color=purple>'''NeuGc'''</font> or {{#invoke:LBS|FormatSugar|NeuAca2-6Glcb1-Cer}}
 |}
 |-
@@ Line 248: / Line 248: @@
 {| style="width:100%"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*GalNAc.1-4Glc.1-Cer|Schisto]]<ref>Makaaru CK, Damian RT, Smith DF, Cummings RD. "The human blood fluke Schistosoma mansoni synthesizes a novel type of glycosphingolipid" J Biol Chem 1992 267:2251-2257 PMID 1733932</ref>
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GalNAcb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4Glcb1-Cer}}
 |}
 |-
@@ Line 273: / Line 273: @@
 {|style="width:100%"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*GlcN.1-.Ins-P-Cer|Protozoa & Fungi-specific]]
-| style="border:0;text-align:right"| {{LBS/FormatSugar|GlcNa/b1-2/6Ins1-P-Cer}}
+| style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcNa/b1-2/6Ins1-P-Cer}}
 |}
 |-
@@ Line 281: / Line 281: @@
 {|style="width:100%"
 |style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*GlcA.1-.Ins-P-Cer|Plant-specific]]
-|style="border:0;text-align:right"| {{LBS/FormatSugar|GlcAa/b1-2/6Ins1-P-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcAa/b1-2/6Ins1-P-Cer}}
 |}
 |-
@@ Line 289: / Line 289: @@
 {| style="width:100%"
 | style="border:0;text-align:left"| [[Volatile:ListMol/LBS|Mainchain.*Man.1-.Ins-P-Cer|Fungi-specific]]
-| style="border:0;text-align:right"| {{LBS/FormatSugar|Mana/b1-2/6Ins1-P-Cer}}
+| style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Mana/b1-2/6Ins1-P-Cer}}
 |}
 |-
 | [[Volatile:ListMol/LBStitle|LBSP5|'''P5''']] <br/> ({{#countTitle:LBSP5}} items)
 | style="text-align:right"| Others
-| style="text-align:right"| {{LBS/FormatSugar|Ins1-P-Cer}}
+| style="text-align:right"| {{#invoke:LBS|FormatSugar|Ins1-P-Cer}}
 |}
@@ Line 405: / Line 405: @@
 | '''1'''
 |rowspan="3"| <b>Galactose</b><br/>(&alpha; form)
-| {{LBS/FormatSugar|Gala1-3 ...}}
+| {{#invoke:LBS|FormatSugar|Gala1-3 ...}}
 |-
-| '''2''' || {{LBS/FormatSugar|Gala1-4 ...}}
+| '''2''' || {{#invoke:LBS|FormatSugar|Gala1-4 ...}}
 |-
-| '''3''' || {{LBS/FormatSugar|Gala1-6 ...}}
+| '''3''' || {{#invoke:LBS|FormatSugar|Gala1-6 ...}}
 |-
 | '''4'''
 |rowspan="3"| <b>Galactose</b><br/>(&beta; form)
-| {{LBS/FormatSugar|Galb1-3 ...}}
+| {{#invoke:LBS|FormatSugar|Galb1-3 ...}}
 |-
-| '''5''' || {{LBS/FormatSugar|Galb1-4 ...}}
+| '''5''' || {{#invoke:LBS|FormatSugar|Galb1-4 ...}}
 |-
-| '''6''' || {{LBS/FormatSugar|Galb1-6 ...}}
+| '''6''' || {{#invoke:LBS|FormatSugar|Galb1-6 ...}}
 |}
 |valign="top"|
@@ Line 427: / Line 427: @@
 | '''7'''
 |rowspan="3"| <b>''N''-Acetyl Galactosamine</b><br/>(&beta; form)
-| {{LBS/FormatSugar|GalNAcb1-3 ...}}
+| {{#invoke:LBS|FormatSugar|GalNAcb1-3 ...}}
 |-
-| '''8''' || {{LBS/FormatSugar|GalNAcb1-4 ...}}
+| '''8''' || {{#invoke:LBS|FormatSugar|GalNAcb1-4 ...}}
 |-
-| '''9''' || {{LBS/FormatSugar|GalNAcb1-6 ...}}
+| '''9''' || {{#invoke:LBS|FormatSugar|GalNAcb1-6 ...}}
 |-
 | '''A'''
 |rowspan="3"| <b>''N''-Acetyl Glucosamine</b><br/>(&beta; form)
-| {{LBS/FormatSugar|GlcNAcb1-3 ...}}
+| {{#invoke:LBS|FormatSugar|GlcNAcb1-3 ...}}
 |-
 | '''B'''
-| {{LBS/FormatSugar|GlcNAcb1-4 ...}}
+| {{#invoke:LBS|FormatSugar|GlcNAcb1-4 ...}}
 |-
 | '''C'''
-| {{LBS/FormatSugar|GlcNAcb1-6 ...}}
+| {{#invoke:LBS|FormatSugar|GlcNAcb1-6 ...}}
 |}
 |}
@@ Line 454: / Line 454: @@
 | '''D'''
 |rowspan="2"| <b>Aminated Sugars</b><br/>(Except for Code 7&sim;C)
-| {{LBS/FormatSugar|GalNAc, GalN}}
+| {{#invoke:LBS|FormatSugar|GalNAc, GalN}}
 |-
-| '''E''' || {{LBS/FormatSugar|GlcNAc, GlcN}}
+| '''E''' || {{#invoke:LBS|FormatSugar|GlcNAc, GlcN}}
 |-
 | '''F'''
@@ Line 500: / Line 500: @@
 !colspan="2"| Abbreviations
 |-
-| '''Y''' || {{LBS/FormatSugar|GlcNAcb1-3Manb1-4Glcb1-1Cer}}
+| '''Y''' || {{#invoke:LBS|FormatSugar|GlcNAcb1-3Manb1-4Glcb1-1Cer}}
 |-
-| '''Z''' || {{LBS/FormatSugar|Galb1-4Glcb1-1bCer}}
+| '''Z''' || {{#invoke:LBS|FormatSugar|Galb1-4Glcb1-1bCer}}
 |}
 |}

Category:LBS: Difference between revisions

Revision as of 02:02, 28 January 2023

Contents

Class Overview

History of Sphingolipids

Sphingolipid

Notation

Page/ID-Code Design

First (s1) Digit for Glycosphingolipid

First (s1) Digit for Phosphosphingolipid

Second (s2) Digit

Biosynthesis

Subcategories

L

Navigation

Tools